Modulation of Lnc05 expression
US11033570B2 · kind B2 · utility
2Cited by
188References
13Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 1, 2017 |
| Grant date | Jun 15, 2021 |
| Priority date | — |
| Expiry date | Dec 1, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/341
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are methods, compounds, and compositions for reducing expression of Inc05 in a cell or individual. Such methods, compounds, and compositions are useful to treat, prevent, delay, or ameliorate a cancer in an individual.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.